Quest Diagnostics (DGX) Treasury Shares (2009 - 2026)

Quest Diagnostics has reported Treasury Shares for 18 years, with the latest figure at $5.2 billion in Q2 2026.

• Quarterly Treasury Shares rose 8.38% year-over-year to $5.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.2 billion (up 8.38% YoY) and the FY2025 annual result came in at $5.2 billion, up 6.65% from the prior year.
• Treasury Shares climbed to $5.2 billion in Q2 2026 per DGX's latest filing, from $5.1 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $52.0 million in Q4 2025 and troughed at $1.1 million in Q4 2022.
• A 5-year average of $44.4 million and a median of $50.0 million in 2023 frame the typical range for Treasury Shares.
• The widest YoY moves for Treasury Shares: up 49.02% in 2022, down 43.41% in 2022.
• Over 5 years, Treasury Shares stood at $4.7 billion in 2022, then climbed by 3.27% to $4.8 billion in 2023, then advanced by 0.64% to $4.9 billion in 2024, then rose by 6.65% to $5.2 billion in 2025, then retreated by 0.15% to $5.2 billion in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $5.2 billion, $5.1 billion, and $5.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.